Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia

Clinical Outcomes Among a National Veterans Affairs Methicillin Resistant Staphylococcus Aureus (MRSA) Pneumonia Cohort Treated With Linezolid Or Vancomycin

The purpose of this non-interventional, retrospective study of existing data is to evaluate clinical outcomes related to Methicillin-resistant Staphylococcus aureus hospital based pneumonia by treatment and among subpopulations.

All patients meeting inclusion/exclusion criteria from inpatient database from 1/1/02-9/30/10.

Inclusion Criteria:

• MRSA and pneumonia cases by ICD-9 code identification.
• Diagnosis included during inpatient stay.
• Treatment initiation in hospital.

Exclusion Criteria:

• Death of discharge within 3 days of treatment initiation.
• Exposure to other treatments with MRSA activity.